Clinical Trial Update: Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing acetazolamide to dapagliflozin in patients with acute decompensated heart failure is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure

Drugs mentioned

• Diamox (acetazolamide)
• Forxiga (dapagliflozin)

Snippet

Sponsor: Helwan University | Conditions: Acute Decompensated Heart Failure | Phase 3 | Status: RECRUITING